Spatial Repellents for Malaria Control

Inclusion Criteria: * Children ≥ 6 months to ≤ 59 months * Children ≥ 6 months to ≤ 59 months with Hb \> 7g/dL and no other serious illness * Sleeps in cluster (i.e. study area) ≥ 90% of nights during any given month * Not participating in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure during the Trial * Provision of informed consent form (ICF) signed by the parent(s) or guardian Exclusion Criteria: * Children \< 6 months and \> 59 months * Children ≥ 6 months to ≤ 59 months with Hb ≤ 7g/dL with signs of other serious illness or Hb ≤ 7 g/dL with signs of clinical decompensation * Sleeps in cluster (i.e. study area) \< 90% of nights during any given month * Participating or planned participation in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure during the trial * No provision of ICF signed by the parent(s) or guardian